Dose-response relationships for alendronate treatment in osteoporotic elderly women von BONE, H. G, DOWNS, R. W, POLVINO, W. J, TUCCI, J. R, HARRIS, S. T, WEINSTEIN, R. S, LICATA, A. A, MCCLUNG, M. R, KIMMEL, D. B, GERTZ, B. J, HALE, E

Volltext

Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults von CHAPMAN, I. M, PESCOVITZ, O. H, THORNER, M. O, MURPHY, G, TREEP, T, CERCHIO, K. A, KRUPA, D, GERTZ, B, POLVINO, W. J, SKILES, E. H, PEZZOLI, S. S

Volltext

Initial human experience with MK-462 (rizatriptan): a novel 5-HT1D agonist von Sciberras, D G, Polvino, W J, Gertz, B J, Cheng, H, Stepanavage, M, Wittreich, J, Olah, T, Edwards, M, Mant, T

Volltext

PHARMACOKINETICS AND FOOD INTERACTION OF MK-462 IN HEALTHY MALES von Cheng, Haiyung, Polvino, William J., Sciberras, David, Yogendran, L., Cerchio, Kristine A., Christie, Karen, Olah, Timothy V., McLoughlin, Debra, James, Ian, Rogers, J. Douglas

Volltext

Gastrokinetic effect of ghrelin analog RC-1139 in the rat Effect on post-operative and on morphine induced ileus von POITRAS, Pierre, POLVINO, William J, ROCHELEAU, Bernard

Volltext

Molecular cloning and nucleotide sequence of cDNA encoding a functional murine low-density-lipoprotein receptor von POLVINO, W. J, DICHEK, D. A, MASON, J, FRENCH ANDERSON, W

Volltext

Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers von Bone, H G, Downs, Jr, R W, Tucci, J R, Harris, S T, Weinstein, R S, Licata, A A, McClung, M R, Kimmel, D B, Gertz, B J, Hale, E, Polvino, W J

Volltext

Initial human experience with MK-462 (rizatriptan) : a novel 5-HT ID agonist von SCIBERRAS, D. G, POLVINO, W. J, GERTZ, B. J, CHENG, H, STEPANAVAGE, M, WITTREICH, J, OLAH, T, EDWARDS, M, MANT, T

Volltext

Pharmacokinetics of extended release diltiazem in elderly subjects von Polvino, WJ, Portas, A, Laskin, O, Cerchio, K, Chiou, R., Han, R, Hoagland, V, Lasseter, K

Volltext

D5Effect Of Food On The Pharmacokinetics Of Extended Release Diltiazem von Cerchio, K, Seibold, J, Porras, AG, Chiou, R, McNamara, M, Laskin, O, Polvino, WJ

Volltext

Effect of food on the pharmacokinetics of extended release diltiazem von Cerchio, K, Seibold, J, Porras, AG, Chiou, R, McNamara, M, Laskin, O, Polvino, WJ

Volltext

D4Pharmacokinetics Of Extended Release Diltiazem In Elderly Subjects von Polvino, WJ, Porras, A, Laskin, O, Cerchio, K, Chiou, R., Han, R, Hoagland, V, Lasseter, K

Volltext

Improved protein analysis on nitrocellulose membranes von Polvino, William J., Saravis, Calvin A., Sampson, Christian E., Cook, Richard B.

Volltext

Porous support for electroblot transfers von Saravis, Calvin A., Cook, Richard B., Polvino, William J., Sampson, Christian E.

Volltext

Two-dimensional (crossed) immunoelectrophoresis template procedure: Use of preformed media von Saravis, Calvin A., Cook, Richard B., Sampson, Christian E., Polvino, William J.

Volltext

MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism von MURPHY, M. G, PLUNKETT, L. M, GERTZ, B. J, HE, W, WITTREICH, J, POLVINO, W. M, CLEMMONS, D. R

Volltext

Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure von SVENSSON, J, LÖNN, L, SJÖSTRÖM, L, BENGTSSON, B.-A, JANSSON, J.-O, MURPHY, G, WYSS, D, KRUPA, D, CERCHIO, K, POLVINO, W, GERTZ, B, BOSEAUS, I

Volltext

A phase II randomized, placebo-controlled, double-blind study of the efficacy and safety of RC-1291 (RC) for the treatment of cancer cachexia von Garcia, J., Boccia, R. V., Graham, C., Kumor, K., Polvino, W.

Volltext

Treatment with the Oral Growth Hormone Secretagogue MK‐677 Increases Markers of Bone Formation and Bone Resorption in Obese Young Males von Svensson, J., Ohlsson, C., Jansson, J.‐O., Murphy, G., Wyss, D., Krupa, D., Cerchio, K., Polvino, W., Gertz, B., Baylink, D., Mohan, S., Bengtsson, B.‐Å.

Volltext

Pharmacokinetics, pharmacodynamics, and dose-response relationship of repaglinide in type 2 diabetes von Strange, P, Schwartz, S L, Graf, R J, Polvino, W, Weston, I, Marbury, T C, Huang, W C, Goldberg, R B

Volltext